Companies using Illumina DNA Sequencing
We have data on 1,615 companies that use Illumina DNA Sequencing. The companies using Illumina DNA Sequencing are most often found in United States and in the Biotechnology industry. Illumina DNA Sequencing is most often used by companies with 1000-5000 employees and 200M-1000M dollars in revenue. Our data for Illumina DNA Sequencing usage goes back as far as 8 years and 9 months.
Who uses Illumina DNA Sequencing?
| Company | The United States Geological Survey |
| Website | usgs.gov |
| Country | United States |
| Revenue | >1000M |
| Company Size | 5000-10000 |
| Company | Phosphorus |
| Website | phosphorus.com |
| Country | United States |
| Revenue | 1M-10M |
| Company Size | 10-50 |
| Company | Novo Nordisk A/S |
| Website | novonordisk.com |
| Country | Denmark |
| Revenue | >1000M |
| Company Size | >10000 |
| Company | NYGC |
| Website | nygenome.org |
| Country | United States |
| Revenue | 10M-50M |
| Company Size | 200-500 |
| Company | Fulgent Genetics |
| Website | fulgentgenetics.com |
| Country | United States |
| Revenue | 200M-1000M |
| Company Size | 500-1000 |
| Company | Website | Country | Revenue | Company Size |
|---|---|---|---|---|
| The United States Geological Survey | usgs.gov | United States | >1000M | 5000-10000 |
| Phosphorus | phosphorus.com | United States | 1M-10M | 10-50 |
| Novo Nordisk A/S | novonordisk.com | Denmark | >1000M | >10000 |
| NYGC | nygenome.org | United States | 10M-50M | 200-500 |
| Fulgent Genetics | fulgentgenetics.com | United States | 200M-1000M | 500-1000 |
Target Illumina DNA Sequencing customers to accomplish your sales and marketing goals.
Illumina DNA Sequencing Market Share and Competitors in Healthcare
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Healthcare. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Healthcare category, Illumina DNA Sequencing has a market share of about 1.1%. Other major and competing products in this category include:
Healthcare
What is Illumina DNA Sequencing?
For DNA sequencing, Illumina's next-generation sequencing (NGS) technology uses clonal amplification and sequencing by synthesis (SBS) chemistry to enable rapid, accurate sequencing. The process simultaneously identifies DNA bases while incorporating them into a nucleic acid chain.
Top Industries that use Illumina DNA Sequencing
Looking at Illumina DNA Sequencing customers by industry, we find that Biotechnology (22%), Higher Education (20%), Hospital & Health Care (13%) and Research (10%) are the largest segments.
Top Countries that use Illumina DNA Sequencing
56% of Illumina DNA Sequencing customers are in United States and 7% are in United Kingdom.
Distribution of companies that use Illumina DNA Sequencing based on company size (Employees)
Of all the customers that are using Illumina DNA Sequencing, 18% are small (<50 employees), 34% are medium-sized and 48% are large (>1000 employees).
Distribution of companies that use Illumina DNA Sequencing based on company size (Revenue)
Of all the customers that are using Illumina DNA Sequencing, 35% are small (<$50M), 17% are medium-sized and 42% are large (>$1000M).
